[{"name":"From p-values to patient-centricity: refining our approach to metastatic breast cancer treatment (ID 833)","mode":"","is_cme":false,"info":{"presentation":"From p-values to patient-centricity: refining our approach to metastatic breast cancer treatment <small>(ID 833)<\/small>","session":"Pfizer - Industry Satellite Symposium: Optimising breast cancer outcomes: Clinical and real-world experience lead to strength in numbers <small>(ID 85)<\/small>","presenter":"Hope S. Rugo<small> (San Francisco, CA, United States of America)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/breast2020\/persons\/photos\/60.jpg"},"playlist":[{"name":"From p-values to patient-centricity: refining our approach to metastatic breast cancer treatment","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/85\/v\/833_2p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/85\/v\/833_2p.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/85\/v\/833_2p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/85\/v\/833_2p-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"9L240fn02Vk"}